• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SFRP4 基因表达在侵袭性前列腺癌中增加。

SFRP4 gene expression is increased in aggressive prostate cancer.

机构信息

Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.

Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.

出版信息

Sci Rep. 2017 Oct 27;7(1):14276. doi: 10.1038/s41598-017-14622-3.

DOI:10.1038/s41598-017-14622-3
PMID:29079735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5660209/
Abstract

Increased knowledge of the molecular differences between indolent and aggressive prostate cancer is needed for improved risk stratification and treatment selection. Secreted frizzled-related protein 4 (SFRP4) is a modulator of the cancer-associated Wnt pathway, and previously suggested as a potential marker for prostate cancer aggressiveness. In this study, we investigated and validated the association between SFRP4 gene expression and aggressiveness in nine independent cohorts (n = 2157). By differential expression and combined meta-analysis of all cohorts, we detected significantly higher SFRP4 expression in cancer compared with normal samples, and in high (3-5) compared with low (1-2) Grade Group samples. SFRP4 expression was a significant predictor of biochemical recurrence in six of seven cohorts and in the overall analysis, and was a significant predictor of metastatic event in one cohort. In our study cohort, where metabolic information was available, SFRP4 expression correlated significantly with the concentrations of citrate and spermine, two previously suggested biomarkers for aggressive prostate cancer. SFRP4 immunohistochemistry in an independent cohort (n = 33) was not associated with aggressiveness. To conclude, high SFRP4 gene expression is associated with high Grade Group and recurrent prostate cancer after surgery. Future studies investigating the mechanistic and clinical usefulness of SFRP4 in prostate cancer are warranted.

摘要

需要更多地了解惰性和侵袭性前列腺癌之间的分子差异,以改善风险分层和治疗选择。分泌卷曲相关蛋白 4(SFRP4)是癌症相关 Wnt 通路的调节剂,先前被认为是前列腺癌侵袭性的潜在标志物。在这项研究中,我们在九个独立队列(n=2157)中研究并验证了 SFRP4 基因表达与侵袭性之间的关联。通过对所有队列的差异表达和合并荟萃分析,我们发现癌症组织中的 SFRP4 表达明显高于正常组织,而在高(3-5)分级组中明显高于低(1-2)分级组。SFRP4 表达是六个队列中七个队列和总体分析中生化复发的显著预测因子,在一个队列中是转移性事件的显著预测因子。在我们的研究队列中,有代谢信息可用,SFRP4 表达与柠檬酸和精胺的浓度显著相关,这两种物质之前被认为是侵袭性前列腺癌的生物标志物。在一个独立队列(n=33)中进行的 SFRP4 免疫组织化学分析与侵袭性无关。总之,高 SFRP4 基因表达与手术后高分级组和复发性前列腺癌有关。未来研究 SFRP4 在前列腺癌中的机制和临床应用价值是有必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/79f2cb3453a5/41598_2017_14622_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/a2f9a50b3af3/41598_2017_14622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/f4244fe3b533/41598_2017_14622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/e68808e448d8/41598_2017_14622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/79f2cb3453a5/41598_2017_14622_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/a2f9a50b3af3/41598_2017_14622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/f4244fe3b533/41598_2017_14622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/e68808e448d8/41598_2017_14622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9301/5660209/79f2cb3453a5/41598_2017_14622_Fig4_HTML.jpg

相似文献

1
SFRP4 gene expression is increased in aggressive prostate cancer.SFRP4 基因表达在侵袭性前列腺癌中增加。
Sci Rep. 2017 Oct 27;7(1):14276. doi: 10.1038/s41598-017-14622-3.
2
Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.分泌型卷曲相关蛋白4抑制前列腺癌的增殖和转移潜能。
Prostate. 2007 Jul 1;67(10):1081-90. doi: 10.1002/pros.20607.
3
Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.分泌型卷曲相关蛋白4的膜表达预示局限性前列腺癌预后良好,并在体外抑制PC3细胞增殖。
Clin Cancer Res. 2004 Jan 15;10(2):615-25. doi: 10.1158/1078-0432.ccr-0707-03.
4
A novel non-canonical Wnt signature for prostate cancer aggressiveness.一种用于前列腺癌侵袭性的新型非经典Wnt信号特征。
Oncotarget. 2017 Feb 7;8(6):9572-9586. doi: 10.18632/oncotarget.14161.
5
Low expression of secreted frizzled-related protein 4 in aggressive pituitary adenoma.分泌型卷曲相关蛋白4在侵袭性垂体腺瘤中的低表达
Pituitary. 2015 Jun;18(3):335-42. doi: 10.1007/s11102-014-0579-4.
6
Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.评估分泌生长激素的垂体腺瘤中sFRP4作为预测侵袭性和复发的生物标志物的作用。
Oncol Rep. 2016 May;35(5):2991-9. doi: 10.3892/or.2016.4650. Epub 2016 Mar 3.
7
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.分泌型卷曲相关蛋白 4 的缺失与卵巢癌患者侵袭性表型相关,并预示不良预后。
PLoS One. 2012;7(2):e31885. doi: 10.1371/journal.pone.0031885. Epub 2012 Feb 21.
8
Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.人心外膜脂肪组织来源和循环分泌卷曲相关蛋白 4(SFRP4)水平在冠心病患者中增加。
Cardiovasc Diabetol. 2017 Oct 16;16(1):133. doi: 10.1186/s12933-017-0612-9.
9
Study on the gene polymorphism and expression in prostate cancer.前列腺癌基因多态性与表达的研究。
J Genet. 2020;99.
10
Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.分泌型卷曲相关蛋白 4(sFRP4)可使源自人乳腺癌、前列腺癌和卵巢癌细胞系的肿瘤干细胞对化疗药物敏感。
Sci Rep. 2017 May 23;7(1):2256. doi: 10.1038/s41598-017-02256-4.

引用本文的文献

1
Transcriptomic Profile of Perineural Invasion in Prostate Cancer Identifies Prognostic Gene Signatures.前列腺癌神经周围侵犯的转录组图谱确定了预后基因特征。
Biomedicines. 2025 Jul 22;13(8):1789. doi: 10.3390/biomedicines13081789.
2
Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer.空间转录组学揭示 SFRP4 与前列腺癌细胞外基质重塑之间的强烈关联。
Commun Biol. 2024 Nov 8;7(1):1462. doi: 10.1038/s42003-024-07161-x.
3
Sfrp4 expression in thyroxine treated calvarial cells.

本文引用的文献

1
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.体外代谢指纹图谱鉴定出可预测前列腺癌根治术后复发的生物标志物。
Br J Cancer. 2017 Nov 21;117(11):1656-1664. doi: 10.1038/bjc.2017.346. Epub 2017 Oct 3.
2
A novel non-canonical Wnt signature for prostate cancer aggressiveness.一种用于前列腺癌侵袭性的新型非经典Wnt信号特征。
Oncotarget. 2017 Feb 7;8(6):9572-9586. doi: 10.18632/oncotarget.14161.
3
SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms.
甲状腺素处理的颅骨细胞中 Sfrp4 的表达。
Life Sci. 2022 Dec 15;311(Pt A):121158. doi: 10.1016/j.lfs.2022.121158. Epub 2022 Nov 9.
4
Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease.前列腺筛状癌的单细胞分析揭示了侵袭性疾病的细胞内在和肿瘤微环境途径。
Nat Commun. 2022 Oct 13;13(1):6036. doi: 10.1038/s41467-022-33780-1.
5
Identification of senescence-related molecular subtypes and key genes for prostate cancer.鉴定前列腺癌相关的衰老分子亚型和关键基因。
Asian J Androl. 2023 Mar-Apr;25(2):223-229. doi: 10.4103/aja202258.
6
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.前列腺原位肿瘤的时空分析表明存在治疗抵抗性克隆的预先存在。
Nat Commun. 2022 Sep 17;13(1):5475. doi: 10.1038/s41467-022-33069-3.
7
SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer.分泌型卷曲相关蛋白4是胃癌预后及免疫治疗的潜在生物标志物。
J Oncol. 2022 Jul 5;2022:8829649. doi: 10.1155/2022/8829649. eCollection 2022.
8
Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.单细胞分析揭示了脂肪组织来源的基质细胞向表达 COL11A1 的癌相关成纤维细胞的泛癌侵袭相关转变。
PLoS Comput Biol. 2021 Jul 20;17(7):e1009228. doi: 10.1371/journal.pcbi.1009228. eCollection 2021 Jul.
9
Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.分泌型卷曲相关蛋白 4 通过 Wnt/β-连环蛋白信号通路在肝癌中发挥抑瘤作用。
Mol Med Rep. 2021 May;23(5). doi: 10.3892/mmr.2021.11975. Epub 2021 Mar 24.
10
Comprehensive Analysis of the Expression and Prognosis for in Breast Carcinoma.在乳腺癌中 的表达与预后的综合分析。
Cell Transplant. 2020 Jan-Dec;29:963689720962479. doi: 10.1177/0963689720962479.
前列腺癌中SFRP1的抑制是由两种不同的表观遗传机制触发的。
Gene. 2016 Nov 30;593(2):292-301. doi: 10.1016/j.gene.2016.08.030. Epub 2016 Aug 26.
4
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease.皮质骨脆性——来自派尔病中sFRP4缺乏的见解。
N Engl J Med. 2016 Jun 30;374(26):2553-2562. doi: 10.1056/NEJMoa1509342.
5
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.TMPRSS2-ERG的存在与人类前列腺癌代谢谱的改变有关。
Oncotarget. 2016 Jul 5;7(27):42071-42085. doi: 10.18632/oncotarget.9817.
6
sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss.依赖分泌型卷曲相关蛋白4(sFRP4)的Wnt信号调节对于出生后发育期间的骨重塑以及与年龄相关的骨质流失至关重要。
Sci Rep. 2016 Apr 27;6:25198. doi: 10.1038/srep25198.
7
The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.高危前列腺癌预后异常基因的研究现状。
Clin Cancer Res. 2016 Apr 1;22(7):1777-86. doi: 10.1158/1078-0432.CCR-15-1250. Epub 2015 Dec 2.
8
The Molecular Taxonomy of Primary Prostate Cancer.原发性前列腺癌的分子分类学
Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.
9
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.前列腺癌组织的表达谱分析确定了与前列腺切除术后复发相关的基因。
Sci Rep. 2015 Nov 2;5:16018. doi: 10.1038/srep16018.
10
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.拷贝数与转录组学整合为前列腺癌提供风险分层:一项发现与验证队列研究。
EBioMedicine. 2015 Jul 29;2(9):1133-44. doi: 10.1016/j.ebiom.2015.07.017. eCollection 2015 Sep.